Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals
Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after...
Gespeichert in:
Veröffentlicht in: | AAOHN journal 2018-06, Vol.66 (6), p.302-309 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 309 |
---|---|
container_issue | 6 |
container_start_page | 302 |
container_title | AAOHN journal |
container_volume | 66 |
creator | Surjadi, Miranda |
description | Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment. |
doi_str_mv | 10.1177/2165079917751479 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1990486898</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2165079917751479</sage_id><sourcerecordid>2043539524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</originalsourceid><addsrcrecordid>eNp1kU1LAzEQhoMoVtS7Jwl48dDVZDefx1I_oeBBPS9pdramtNmaZAv-e1PaKgjOZYbM874TZhC6oOSGUilvSyo4kVrnmlMm9QE62TwVRAt9uK9zf4DOY5yTHFpqxtUxGpS64lowfoLa8UfovLP4CVYmueQiHuNXGwC887Mhvl-bRZ8bnR9i4xv8FsCkJfiE31eNSYCdx-kD8GgGuGvxnQtgUzGyKavxyCe3dsEs4hk6anOC810-Re8P92_jp2Ly8vg8Hk0Ky4hMhZDQSiMNtVOhwNKGt5qZtuJEqYpONaWClNyqkjJbglVQiobLSghBFQDX1Sm63vquQvfZQ0z10kULi4Xx0PWxploTpoTSKqNXf9B51weff1eXhFW80rxkmSJbyoYuxgBtvQpuacJXTUm9OUP99wxZcrkz7qdLaH4E-6VnoNgC0czgd-q_ht_THYz0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2043539524</pqid></control><display><type>article</type><title>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</title><source>Access via SAGE</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Surjadi, Miranda</creator><creatorcontrib>Surjadi, Miranda</creatorcontrib><description>Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment.</description><identifier>ISSN: 2165-0799</identifier><identifier>EISSN: 2165-0969</identifier><identifier>DOI: 10.1177/2165079917751479</identifier><identifier>PMID: 29359645</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Aged ; Antiviral Agents - pharmacology ; Antiviral drugs ; Centers for Disease Control and Prevention (U.S.) ; Disease control ; Employees ; Exposure ; Hepatitis ; Hepatitis C ; Hepatitis C, Chronic - diagnosis ; Hepatitis C, Chronic - therapy ; Humans ; Infectious diseases ; Mass Screening - statistics & numerical data ; Medical personnel ; Middle Aged ; Needlestick injuries ; Nursing ; Occupational exposure ; Occupational Exposure - statistics & numerical data ; Occupational health ; Occupational Health - statistics & numerical data ; Practice Guidelines as Topic ; Risk ; Screening ; United States ; Viruses ; Workplaces</subject><ispartof>AAOHN journal, 2018-06, Vol.66 (6), p.302-309</ispartof><rights>2018 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</citedby><cites>FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/2165079917751479$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/2165079917751479$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29359645$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Surjadi, Miranda</creatorcontrib><title>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</title><title>AAOHN journal</title><addtitle>Workplace Health Saf</addtitle><description>Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment.</description><subject>Aged</subject><subject>Antiviral Agents - pharmacology</subject><subject>Antiviral drugs</subject><subject>Centers for Disease Control and Prevention (U.S.)</subject><subject>Disease control</subject><subject>Employees</subject><subject>Exposure</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C, Chronic - diagnosis</subject><subject>Hepatitis C, Chronic - therapy</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Mass Screening - statistics & numerical data</subject><subject>Medical personnel</subject><subject>Middle Aged</subject><subject>Needlestick injuries</subject><subject>Nursing</subject><subject>Occupational exposure</subject><subject>Occupational Exposure - statistics & numerical data</subject><subject>Occupational health</subject><subject>Occupational Health - statistics & numerical data</subject><subject>Practice Guidelines as Topic</subject><subject>Risk</subject><subject>Screening</subject><subject>United States</subject><subject>Viruses</subject><subject>Workplaces</subject><issn>2165-0799</issn><issn>2165-0969</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1LAzEQhoMoVtS7Jwl48dDVZDefx1I_oeBBPS9pdramtNmaZAv-e1PaKgjOZYbM874TZhC6oOSGUilvSyo4kVrnmlMm9QE62TwVRAt9uK9zf4DOY5yTHFpqxtUxGpS64lowfoLa8UfovLP4CVYmueQiHuNXGwC887Mhvl-bRZ8bnR9i4xv8FsCkJfiE31eNSYCdx-kD8GgGuGvxnQtgUzGyKavxyCe3dsEs4hk6anOC810-Re8P92_jp2Ly8vg8Hk0Ky4hMhZDQSiMNtVOhwNKGt5qZtuJEqYpONaWClNyqkjJbglVQiobLSghBFQDX1Sm63vquQvfZQ0z10kULi4Xx0PWxploTpoTSKqNXf9B51weff1eXhFW80rxkmSJbyoYuxgBtvQpuacJXTUm9OUP99wxZcrkz7qdLaH4E-6VnoNgC0czgd-q_ht_THYz0</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Surjadi, Miranda</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201806</creationdate><title>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</title><author>Surjadi, Miranda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-67ef7a7a1cb68ec1d5f94af3508831b9116025c8214c2ec8e26d57366618ee593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Antiviral Agents - pharmacology</topic><topic>Antiviral drugs</topic><topic>Centers for Disease Control and Prevention (U.S.)</topic><topic>Disease control</topic><topic>Employees</topic><topic>Exposure</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C, Chronic - diagnosis</topic><topic>Hepatitis C, Chronic - therapy</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Mass Screening - statistics & numerical data</topic><topic>Medical personnel</topic><topic>Middle Aged</topic><topic>Needlestick injuries</topic><topic>Nursing</topic><topic>Occupational exposure</topic><topic>Occupational Exposure - statistics & numerical data</topic><topic>Occupational health</topic><topic>Occupational Health - statistics & numerical data</topic><topic>Practice Guidelines as Topic</topic><topic>Risk</topic><topic>Screening</topic><topic>United States</topic><topic>Viruses</topic><topic>Workplaces</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Surjadi, Miranda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>AAOHN journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Surjadi, Miranda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals</atitle><jtitle>AAOHN journal</jtitle><addtitle>Workplace Health Saf</addtitle><date>2018-06</date><risdate>2018</risdate><volume>66</volume><issue>6</issue><spage>302</spage><epage>309</epage><pages>302-309</pages><issn>2165-0799</issn><eissn>2165-0969</eissn><abstract>Globally, hepatitis C virus (HCV), the cause of one of the most common infectious diseases, infects approximately 4 million to 5 million Americans with approximately half of infected individuals undiagnosed. Some workplaces screen employees for HCV exposure and other bloodborne pathogens (BBP) after needlestick injuries, but it is not well known whether employers screen employees for HCV without an occupational exposure. New guidelines from the Centers for Disease Control and Prevention (CDC) recommend that all individuals born between 1945 and 1965 should be screened for HCV regardless of risk; this provides an opportunity at the worksite for HCV outreach to employees, dependents, and retirees. To understand this recommendation, the management of HCV in the age of direct-acting antivirals (DAAs) should be reviewed. Now that new DAA treatment can cure HCV, occupational health nurses should identify potential HCV-positive individuals at the worksite via HCV education, screening, testing, and, if positive, linking to specialists for treatment.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>29359645</pmid><doi>10.1177/2165079917751479</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2165-0799 |
ispartof | AAOHN journal, 2018-06, Vol.66 (6), p.302-309 |
issn | 2165-0799 2165-0969 |
language | eng |
recordid | cdi_proquest_miscellaneous_1990486898 |
source | Access via SAGE; MEDLINE; Alma/SFX Local Collection |
subjects | Aged Antiviral Agents - pharmacology Antiviral drugs Centers for Disease Control and Prevention (U.S.) Disease control Employees Exposure Hepatitis Hepatitis C Hepatitis C, Chronic - diagnosis Hepatitis C, Chronic - therapy Humans Infectious diseases Mass Screening - statistics & numerical data Medical personnel Middle Aged Needlestick injuries Nursing Occupational exposure Occupational Exposure - statistics & numerical data Occupational health Occupational Health - statistics & numerical data Practice Guidelines as Topic Risk Screening United States Viruses Workplaces |
title | Chronic Hepatitis C Screening, Evaluation, and Treatment Update in the Age of Direct-Acting Antivirals |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A25%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20Hepatitis%20C%20Screening,%20Evaluation,%20and%20Treatment%20Update%20in%20the%20Age%20of%20Direct-Acting%20Antivirals&rft.jtitle=AAOHN%20journal&rft.au=Surjadi,%20Miranda&rft.date=2018-06&rft.volume=66&rft.issue=6&rft.spage=302&rft.epage=309&rft.pages=302-309&rft.issn=2165-0799&rft.eissn=2165-0969&rft_id=info:doi/10.1177/2165079917751479&rft_dat=%3Cproquest_cross%3E2043539524%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2043539524&rft_id=info:pmid/29359645&rft_sage_id=10.1177_2165079917751479&rfr_iscdi=true |